Hofseth BioCare ASA
Company Profile
Business description
Hofseth BioCare ASA is a Norway-based company engaged in the business of developing, manufacturing, marketing, and selling marine ingredients such as oil, calcium, and protein products. Its products and their respective brands include salmon oil (OmeGo), hydrolyzed soluble protein (ProGo), Calcium/Collagen (CalGo or NT-II), and non-soluble protein (PetGo), all of which are produced in the Midsund plant. The firm sells its products to various segments of the human nutrition market, such as sports nutrition, supplements, and health foods, as well as to the market within nutrition for the pet and feed industry. It generates maximum revenue from the sale of salmon oil. Geographically, the company generates maximum revenue from Europe, followed by North America and Asia.
Contact
Keiser Wilhelms Gate 24
Aalesund6003
NORT: +47 73102200
Sector
Consumer Defensive
Stock type
Defensive
Industry
Packaged Foods
Fiscal Year End
31 December 2025
Employees
78
Stocks News & Analysis
stocks
Nvidia: Collaboration with Intel might bring some goodwill with the US
stocks
What now for Santos after takeover offer collapses?
stocks
Morningstar initiates coverage on small cap ASX REIT
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,061.20 | 20.50 | -0.23% |
CAC 40 | 7,853.59 | 1.02 | -0.01% |
DAX 40 | 23,639.41 | 35.12 | -0.15% |
Dow JONES (US) | 46,315.27 | 172.85 | 0.37% |
FTSE 100 | 9,216.67 | 11.44 | -0.12% |
HKSE | 26,545.10 | 0.25 | 0.00% |
NASDAQ | 22,631.48 | 160.75 | 0.72% |
Nikkei 225 | 45,045.81 | 257.62 | -0.57% |
NZX 50 Index | 13,231.66 | 111.63 | 0.85% |
S&P 500 | 6,664.36 | 32.40 | 0.49% |
S&P/ASX 200 | 8,773.50 | 18.70 | -0.21% |
SSE Composite Index | 3,820.09 | 11.57 | -0.30% |